Variant report
Variant | nsv562212 |
---|---|
Chromosome Location | chr13:70399346-70407024 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7335903 | chr13:70399810-70399811 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs9542095 | chr13:70399842-70399843 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs557711473 | chr13:70399917-70399918 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs564994046 | chr13:70399969-70399970 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs141293549 | chr13:70399974-70399975 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs79781802 | chr13:70399990-70399991 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs148562397 | chr13:70399995-70399996 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs116569580 | chr13:70400081-70400082 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs190824117 | chr13:70400088-70400089 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs575885018 | chr13:70400122-70400123 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs543321599 | chr13:70400123-70400124 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs80142971 | chr13:70400129-70400130 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs397699095 | chr13:70400130-70400131 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs200816876 | chr13:70400131-70400132 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs7336219 | chr13:70400215-70400216 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs540913676 | chr13:70400243-70400244 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs527970477 | chr13:70400245-70400246 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs116253005 | chr13:70400257-70400258 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs78638901 | chr13:70400284-70400285 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs567009787 | chr13:70400286-70400287 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs533195379 | chr13:70400308-70400309 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs76421386 | chr13:70400334-70400335 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs114550239 | chr13:70400353-70400354 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs115103943 | chr13:70400379-70400380 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs551119171 | chr13:70400423-70400424 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs369171195 | chr13:70400466-70400467 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs530549028 | chr13:70400467-70400468 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs549145582 | chr13:70400471-70400472 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs570054827 | chr13:70400479-70400480 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs561689887 | chr13:70400563-70400564 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs534911929 | chr13:70400589-70400590 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs567364151 | chr13:70400604-70400605 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs199924029 | chr13:70400610-70400611 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs557805712 | chr13:70400627-70400628 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs372221440 | chr13:70400651-70400652 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs531005333 | chr13:70400654-70400655 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs115504679 | chr13:70400671-70400672 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs182140978 | chr13:70400672-70400673 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs75081775 | chr13:70400674-70400675 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs185529669 | chr13:70400684-70400685 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs144260651 | chr13:70400710-70400711 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs369381884 | chr13:70400711-70400712 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs567632654 | chr13:70400739-70400740 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs544378728 | chr13:70400743-70400744 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs141048000 | chr13:70400780-70400781 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs144908760 | chr13:70400788-70400789 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs6562596 | chr13:70400798-70400799 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs190057724 | chr13:70400844-70400845 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs11372220 | chr13:70400913-70400914 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs34647588 | chr13:70400914-70400915 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Prostate cancer | 16461572 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Prostate cancer | 22341455 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:70399800-70400200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
2 | chr13:70399800-70400400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
3 | chr13:70399800-70400600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr13:70400000-70400600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
5 | chr13:70400000-70400800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
6 | chr13:70400200-70402200 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
7 | chr13:70402000-70403600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
8 | chr13:70402200-70403200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
9 | chr13:70402200-70403400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
10 | chr13:70402600-70403200 | Enhancers | Adipose Nuclei | Adipose |
11 | chr13:70402600-70403200 | Enhancers | Placenta Amnion | Placenta Amnion |
12 | chr13:70402800-70403000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
13 | chr13:70402800-70403200 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |